WUXI, China, June 20, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced today that
Growth Capitalist (https://growthcapitalist.com/2018/06/wuxi-biologics-initiated-construction-of-a-state-of-the-art-integrated-adc-solution-center/)
WUXI, China, June 20, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced today that